Related Experiment Video

Updated: Aug 7, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
04:40

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

[Coronary calcium and statins therapy]

M B Bel'kind, V E Sinitsyn, A A Liakishev

    Terapevticheskii Arkhiv
    |July 11, 2006
    PubMed

    Insights

    Statin therapy slowed coronary calcium score (CCS) progression in patients with coronary heart disease (CHD) and hyperlipidemia. This suggests CCS monitoring with computed tomography is valuable for assessing treatment effectiveness.

    Area of Science:

    • Cardiology
    • Radiology
    • Pharmacology

    Background:

    • Coronary heart disease (CHD) and hyperlipidemia are significant risk factors for cardiovascular events.
    • Statin therapy is a cornerstone in managing hyperlipidemia and reducing cardiovascular risk.
    • Assessing the progression of coronary atherosclerosis is crucial for patient management.

    Purpose of the Study:

    • To evaluate the effect of statin therapy on the progression of coronary calcium score (CCS) in patients with CHD and hyperlipidemia.
    • To determine if CCS dynamics, measured by electron-beam tomography (EBT), can serve as a marker for treatment response.
    • To explore the relationship between changes in total cholesterol and CCS progression.

    Main Methods:

    • A prospective study involving 119 hyperlipidemic CHD patients.
    • Patients were divided into a statin treatment group (n=69) and a control group (n=50).
    • Coronary calcium score (CCS) was assessed using electron-beam tomography (EBT) at baseline and during a mean follow-up of 25.3 months.

    Main Results:

    • The statin group showed a significantly lower mean increase in CCS (27.1%) compared to the control group (65.2%) (p=0.044).
    • Total plasma cholesterol decreased by 25.1% in the statin group versus a 0.5% decrease in the control group.
    • A significant negative correlation was observed between the reduction in total cholesterol and the increment in CCS (r=-0.243, p=0.008).

    Conclusions:

    • Calcium scoring using EBT or CT is effective for the pre-clinical diagnosis of coronary atherosclerosis.
    • CCS monitoring can be utilized to track the progression of coronary atherosclerosis during hyperlipidemic therapy.
    • Statin therapy demonstrates a beneficial effect in slowing the progression of coronary calcification.
    Abstract

    Related Concept Videos

    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...